Developer docs
API playgroundTry for free, no card

Search company profiles

System Biosciences

Full company profile

uuid0008ikq

Namestring
System Biosciences
Legal namestring
System Biosciences, LLC
Websiteurl
systembio.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

System Biosciences (SBI), founded in 2004 and headquartered in Palo Alto, California (with a Newark, CA operations address), is a privately-held biotechnology tools company that develops and commercializes molecular and cell biology research reagents and services. Its portfolio spans seven core product categories - exosome research (isolation, engineering, detection, quantitation, and biomarker discovery tools including ExoQuick UltraPure and SmartSEC systems), CRISPR/Cas9 systems, lentivirus production (pPACKH1, pPACKF1, pPACK-ID packaging kits and the 293TN producer cell line), gene expression platforms (lentiviral vectors, PiggyBac transposon, Minicircle, EEV episomal vectors, SparQ cumate-inducible systems, AAV, mRNA synthesis, Cold Fusion cloning), imaging and reporter vectors, miRNA/lncRNA tools, and liquid biopsy - supported by a citation library of thousands of peer-reviewed publications.

The company monetizes through two channels: (1) catalog product sales priced individually (typically $500-$3,000 per SKU) distributed via its e-commerce storefront at systembio.com, direct sales, and a worldwide distributor network, with commercial-use licensing restrictions on key platforms such as PiggyBac, Minicircle, and EEV that create incremental license revenue; and (2) fee-for-service custom work (Syn2Clone constructs, lentivirus packaging, stable cell line generation, minicircle production, CRISPR cell line engineering, exosome services including Exo-NGS/proteomics/lipidomics, and RNA services) delivered on-site at the Palo Alto facility.

SBI's primary customer base is academic researchers (university labs in neuroscience, cancer, gene therapy, stem cell, and exosome biology), supplemented by biotech and pharmaceutical companies that procure both catalog reagents and custom services for gene therapy, cell therapy, and drug discovery programs. The company employs 11-50 people and operates without disclosed institutional funding beyond a 2004 Kenson Ventures seed, funding ongoing operations and product development from internal cash flow. Its founder-led structure (Kenneth Fong and Tim Avila) and 20-year operating history position it as an established but sub-scale specialist in a fragmented life-science tools market.

Short descriptiontext

System Biosciences is a privately-held biotech tools company that develops and sells molecular and cell biology research reagents - including exosome isolation kits, CRISPR/Cas9 systems, lentiviral packaging, and gene expression platforms - alongside fee-for-service custom work, serving academic researchers and biotech/pharma customers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPalo Alto, United States
HQ citystring
Palo Alto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular biology reagents, exosome research products, CRISPR gene editing, lentiviral packaging kits, gene expression vectors
Industry3 codes
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAKAD
Viral Vector Manufacturing Services (AAV, lentiviral, adenoviral)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Biological Products, (No Disgnostic Substances)2836
Product category
Life Science Research Reagents
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Research Product Sales
TypeOne Time License
Description

SBI generates revenue primarily through the sale of molecular biology research reagents and kits including lentiviral packaging kits, CRISPR tools, exosome isolation kits, gene expression vectors, imaging reporters, and related consumables. Products are sold directly via the company website (e-commerce) and through a worldwide distributor network.

systembio.com
2Custom Research Services
TypeProfessional Services
Description

SBI offers fee-for-service custom molecular biology services including Syn2Clone custom construct construction, lentivirus packaging, stable cell line generation, minicircle production services, CRISPR/Cas9 cell line engineering, exosome services (Exo-NGS, proteomics, lipidomics/metabolomics), and RNA services (mRNA synthesis, miRNA/lncRNA profiling). Services are priced per project and delivered from the Palo Alto, CA facility.

systembio.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details11 tiers
1293TN Producer Cell Line
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Catalog #LV900A-1: 2 x 10^6 Cells — $521.00

systembio.com
2pPACKH1 HIV Lentivector Packaging Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

LV500A-1 (10 transfections): $615.00; LV510A-1 (25 transfections): $1,339.00

systembio.com
3pPACKF1 FIV Lentivector Packaging Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

LV100A-1 (10 transfections): $803.00; LV100A-5 (50 transfections): $3,159.00

systembio.com
4pPACK-ID Integrase-defective Lentiviral Packaging Mix
ModelUnit PricingBilling cadencePay-as-you-go
Notes

LV520A-ID (15 reactions): $910.00; LV525A-ID (30 reactions): $1,500.00

systembio.com
5mRNAExpress mRNA Synthesis Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

MR-KIT-1 (5 reactions): $1,596.00

systembio.com
6MC-Easy Minicircle DNA Production Kit with Competent Cells
ModelUnit PricingBilling cadencePay-as-you-go
Notes

MN920A-1 (5 preps): $1,636.00; MN925A-1 (10 preps): $2,901.00

systembio.com
7ZYCY10P3S2T E. coli Minicircle Producer Strain
ModelUnit PricingBilling cadencePay-as-you-go
Notes

MN900A-1 (5 vials): $876.00. Note: available for not-for-profit researchers only; commercial users purchase pre-made minicircle DNA only.

systembio.com
8pMSCV-Human Foxp3-EF1α-GFP-T2A-Puro (PiggyBac plasmid)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

TCL200PB-1 (10 µg): $985.00. Academic customers: internal research use; Commercial customers: 6-month limited-use license via agreement.

systembio.com
9CuO-Mouse Foxp3 Cumate-Inducible Lentivector
ModelUnit PricingBilling cadencePay-as-you-go
Notes

TCL500A-1 (10 µg): $1,888.00

systembio.com
10Custom Minicircle Services
ModelOtherBilling cadenceMulti-year contract
Notes

End-to-end service (4-week typical turnaround) covering cloning and production. Typical quantities: 250 µg to 10 mg. Custom quotes via services@systembio.com. For-profit organizations purchase pre-made minicircle DNA through the production service with no licensing restrictions for research use.

systembio.com
11Custom Reporter Cell Line Generation Services
ModelOtherBilling cadenceMulti-year contract
Notes

End-to-end service including construct building and cell line delivery. Quote-based. All projects completed on-site in Palo Alto, CA facility.

systembio.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

System Biosciences (SBI) develops, manufactures, and sells molecular and cell biology research tools—including exosome isolation kits, CRISPR/Cas9 gene editing systems, lentiviral packaging kits, gene expression vectors (minicircles, EEV, PiggyBac), imaging/reporters, miRNA/lncRNA tools, and liquid biopsy reagents—through its e-commerce catalog and worldwide distributor network. The company also provides fee-for-service custom research services (lentivirus packaging, stable cell line generation, minicircle production, CRISPR cell engineering, exosome services, RNA services, Syn2Clone constructs) executed at its Palo Alto, California facility.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Up to 32-fold gene expression induction with SparQ cumate-inducible systems
+3 more records
Product overview1 text field

System Biosciences (SBI) offers a comprehensive portfolio of molecular and cell biology products and services organized into seven core product categories: Exosome Research (isolation, engineering, detection, and quantitation kits including ExoQuick® UltraPure and SmartSEC™ systems), CRISPR/Cas9 Systems (genome editing tools including AAVS1 SparQ™ and EZ-Genotyping), Lentivirus Production (LentiSuite kits, pPACKH1/F1 packaging systems, 293TN cell line), Gene Expression Systems (lentiviral vectors, AAV, PiggyBac Transposon, Minicircle Technology, EEV episomal vectors, Cumate-inducible SparQ systems, PhiC31 integrase, and mRNAExpress synthesis), Imaging & Reporter Vectors (pGreenFire signaling reporters, bioluminescent imaging, stem cell reporters), miRNA & lncRNA Research Tools (precursor vectors, miRZIP knockdown, qPCR profiling), and Liquid Biopsy (cfMAX cfDNA isolation). Additionally, SBI provides fee-for-service offerings including Exosome Services, CRISPR/Cas9 Services, Syn2Clone Custom Constructs, Lentivirus Packaging, Stable Cell Lines, Minicircle Services, and RNA Services. The portfolio enables research spanning biomarker discovery, gene therapy development, gene editing validation, stem cell tracking, and T cell immunology studies.

Product and service7 records
1Exosome Research Product Suite
CategoryExosome Research Reagents
Description

Complete suite of exosome and extracellular vesicle (EV) products covering isolation, detection, quantitation, labeling, engineering, and biomarker discovery, including ExoQuick UltraPure, SmartSEC kits, ExoELISA-ULTRA, and purified exosome reference materials. Used by academic and industry researchers for biomarker discovery, EV biology, and therapeutic development.

2CRISPR/Cas9 Systems
CategoryGenome Editing Reagents
Description

Complete CRISPR/Cas9 genome editing tools including Cas9 and gRNA delivery vectors, multiplex gRNA cloning, HR targeting vectors, AAVS1 safe harbor targeting, EZ-Genotyping kit, and the CLOuD9 gene expression regulation system. For molecular biology researchers performing gene editing studies.

3Lentivirus Production Products
CategoryLentiviral Packaging Reagents
Description

High-titer lentivirus production products including pPACKH1 HIV-based and pPACKF1 FIV-based packaging kits, pPACK-ID integrase-defective packaging, LentiSuite/LentiStarter kits, virus concentration/titering kits, the 293TN producer cell line, and pre-packaged control viruses for gene delivery research.

4Gene Expression Systems
CategoryGene Expression Reagents
Description

Viral and non-viral gene expression platforms including lentiviral vectors, AAV vectors, PiggyBac transposon, Minicircle technology, EEV episomal vectors, SparQ cumate-inducible systems, PhiC31 integrase, mRNAExpress synthesis kits, and Cold Fusion cloning. For researchers requiring sustained or inducible gene expression.

5Imaging and Reporter Vectors
CategoryImaging and Reporter Reagents
Description

Ready-to-use reporter constructs and vectors for bioluminescent imaging (luciferase), fluorescent labeling, signaling pathway analysis (pGreenFire reporters), stem cell monitoring, and Cyto-Tracers for cellular tracking studies.

6miRNA and lncRNA Research Tools
CategoryNoncoding RNA Reagents
Description

Tools for miRNA and long non-coding RNA research including Lenti-miR precursor vectors, Lenti-miR libraries, miRZIP knockdown vectors, and qPCR profiling arrays for noncoding RNA studies.

7Liquid Biopsy Research Products
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Cambridge Biosciences serves as a regional distributor for SBI products in the UK and Ireland. Academic researchers in these regions can purchase SBI products including minicircle vectors through Cambridge Biosciences.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Takara Bio
TypeDirect peer
Description

Takara Bio is a Japan-based molecular biology tools and services company with overlapping lentiviral packaging (Lenti-X), gene expression, CRISPR, and cell engineering offerings. It competes most directly with SBI in lentiviral production kits and custom services for academic and pharma researchers.

TypeDirect peer
Description

GenScript provides gene synthesis, CRISPR reagents, viral vector services, and protein/peptide tools. Its viral packaging and gene expression offerings overlap heavily with SBI's lentivirus packaging, Syn2Clone, and CRISPR/Cas9 service lines.

TypeDirect peer
Description

VectorBuilder is a custom vector design and viral packaging service provider (lentivirus, AAV, adenovirus) serving academic and biotech customers. Its custom-cloning and lentivirus-packaging services directly overlap with SBI's Syn2Clone and lentivirus packaging offerings.

TypeDirect peer
Description

Mirus Bio specializes in transfection reagents (TransIT) and gene delivery tools used in molecular biology and bioprocessing workflows. It is a direct peer in gene delivery reagents, competing with SBI's viral packaging, AAV, and non-viral delivery systems.

TypeDirect peer
Description

Cell Biolabs is a San Diego-based life science research tools company offering kits for viral transduction, cell-based assays, exosome research, and gene expression. It is closely comparable to SBI across exosome isolation kits, lentiviral tools, and cell-line reagents.

TypeDirect peer
Description

Addgene is a nonprofit plasmid repository distributing viral vectors, CRISPR constructs, and recombinant antibodies to academic researchers worldwide. It represents an alternative channel for the same lentiviral and CRISPR plasmids that SBI commercializes, making it a competing route for the same end customer.

TypeBroad incumbent
Description

Bio-Techne (R&D Systems, Tocris, ProteinSimple) is a large public life-science tools company with broad reagent, antibody, and cell/gene therapy reagent portfolios. It is a broad incumbent competing with SBI across exosome/EV research tools, gene expression reagents, and stem cell research products.

TypeBroad incumbent
Description

Thermo Fisher is the largest life-science tools and services conglomerate, offering lentiviral packaging, CRISPR reagents, gene expression systems, and custom services through its Life Sciences and Pharma Services segments. It competes with SBI across nearly every product category, although as part of a much wider portfolio.

TypeBroad incumbent
Description

Lonza is a leading CDMO with cell and gene therapy manufacturing services including viral vector production. While focused on GMP/clinical-stage manufacturing, Lonza's viral vector services overlap with SBI's custom lentivirus packaging for translational and early-clinical customers.

TypeEmerging player
Description

Miltenyi Biotec offers cell and gene therapy tools, including lentiviral vectors, exosome/EV isolation reagents, and cell engineering services. It overlaps with SBI in EV research and gene delivery reagents, with growing emphasis on cell therapy workflow tools.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

System Biosciences

Life Science Research Reagentssystembio.com

System Biosciences is a privately-held biotech tools company that develops and sells molecular and cell biology research reagents - including exosome isolation kits, CRISPR/Cas9 systems, lentiviral packaging, and gene expression platforms - alongside fee-for-service custom work, serving academic researchers and biotech/pharma customers globally.

What System Biosciences does

System Biosciences (SBI), founded in 2004 and headquartered in Palo Alto, California (with a Newark, CA operations address), is a privately-held biotechnology tools company that develops and commercializes molecular and cell biology research reagents and services. Its portfolio spans seven core product categories - exosome research (isolation, engineering, detection, quantitation, and biomarker discovery tools including ExoQuick UltraPure and SmartSEC systems), CRISPR/Cas9 systems, lentivirus production (pPACKH1, pPACKF1, pPACK-ID packaging kits and the 293TN producer cell line), gene expression platforms (lentiviral vectors, PiggyBac transposon, Minicircle, EEV episomal vectors, SparQ cumate-inducible systems, AAV, mRNA synthesis, Cold Fusion cloning), imaging and reporter vectors, miRNA/lncRNA tools, and liquid biopsy - supported by a citation library of thousands of peer-reviewed publications.

The company monetizes through two channels: (1) catalog product sales priced individually (typically $500-$3,000 per SKU) distributed via its e-commerce storefront at systembio.com, direct sales, and a worldwide distributor network, with commercial-use licensing restrictions on key platforms such as PiggyBac, Minicircle, and EEV that create incremental license revenue; and (2) fee-for-service custom work (Syn2Clone constructs, lentivirus packaging, stable cell line generation, minicircle production, CRISPR cell line engineering, exosome services including Exo-NGS/proteomics/lipidomics, and RNA services) delivered on-site at the Palo Alto facility.

SBI's primary customer base is academic researchers (university labs in neuroscience, cancer, gene therapy, stem cell, and exosome biology), supplemented by biotech and pharmaceutical companies that procure both catalog reagents and custom services for gene therapy, cell therapy, and drug discovery programs. The company employs 11-50 people and operates without disclosed institutional funding beyond a 2004 Kenson Ventures seed, funding ongoing operations and product development from internal cash flow. Its founder-led structure (Kenneth Fong and Tim Avila) and 20-year operating history position it as an established but sub-scale specialist in a fragmented life-science tools market.

System Biosciences firmographics

Firmographics
Name
System Biosciences
Legal name
System Biosciences, LLC
Website
https://systembio.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
System Biosciences is a privately-held biotech tools company that develops and sells molecular and cell biology research reagents - including exosome isolation kits, CRISPR/Cas9 systems, lentiviral packaging, and gene expression platforms - alongside fee-for-service custom work, serving academic researchers and biotech/pharma customers globally.
Ownership category
akta.pro rank

System Biosciences industry classification

Industry
Product category
Life Science Research Reagents
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAKAD
Viral Vector Manufacturing Services (AAV, lentiviral, adenoviral)

Keywords

  • Molecular biology reagents
  • Exosome research products
  • CRISPR gene editing
  • Lentiviral packaging kits
  • Gene expression vectors

Where System Biosciences is headquartered

Location

Headquarters

HQ city
Palo Alto
HQ country
United States
HQ region
North America

Offices3 records

Markets served

System Biosciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Research Product Sales: SBI generates revenue primarily through the sale of molecular biology research reagents and kits including lentiviral packaging kits, CRISPR tools, exosome isolation kits, gene expression vectors, imaging reporters, and related consumables. Products are sold directly via the company website (e-commerce) and through a worldwide distributor network.
  2. Custom Research Services: SBI offers fee-for-service custom molecular biology services including Syn2Clone custom construct construction, lentivirus packaging, stable cell line generation, minicircle production services, CRISPR/Cas9 cell line engineering, exosome services (Exo-NGS, proteomics, lipidomics/metabolomics), and RNA services (mRNA synthesis, miRNA/lncRNA profiling). Services are priced per project and delivered from the Palo Alto, CA facility.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-go293TN Producer Cell Line
Unit PricingPay-as-you-gopPACKH1 HIV Lentivector Packaging Kit
Unit PricingPay-as-you-gopPACKF1 FIV Lentivector Packaging Kit
Unit PricingPay-as-you-gopPACK-ID Integrase-defective Lentiviral Packaging Mix
Unit PricingPay-as-you-gomRNAExpress mRNA Synthesis Kit
Unit PricingPay-as-you-goMC-Easy Minicircle DNA Production Kit with Competent Cells
Unit PricingPay-as-you-goZYCY10P3S2T E. coli Minicircle Producer Strain
Unit PricingPay-as-you-gopMSCV-Human Foxp3-EF1α-GFP-T2A-Puro (PiggyBac plasmid)
Unit PricingPay-as-you-goCuO-Mouse Foxp3 Cumate-Inducible Lentivector
OtherMulti-year contractCustom Minicircle Services
OtherMulti-year contractCustom Reporter Cell Line Generation Services

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

System Biosciences product offering

Product offering

Core offering

System Biosciences (SBI) develops, manufactures, and sells molecular and cell biology research tools—including exosome isolation kits, CRISPR/Cas9 gene editing systems, lentiviral packaging kits, gene expression vectors (minicircles, EEV, PiggyBac), imaging/reporters, miRNA/lncRNA tools, and liquid biopsy reagents—through its e-commerce catalog and worldwide distributor network. The company also provides fee-for-service custom research services (lentivirus packaging, stable cell line generation, minicircle production, CRISPR cell engineering, exosome services, RNA services, Syn2Clone constructs) executed at its Palo Alto, California facility.

Product overview

System Biosciences (SBI) offers a comprehensive portfolio of molecular and cell biology products and services organized into seven core product categories: Exosome Research (isolation, engineering, detection, and quantitation kits including ExoQuick® UltraPure and SmartSEC™ systems), CRISPR/Cas9 Systems (genome editing tools including AAVS1 SparQ™ and EZ-Genotyping), Lentivirus Production (LentiSuite kits, pPACKH1/F1 packaging systems, 293TN cell line), Gene Expression Systems (lentiviral vectors, AAV, PiggyBac Transposon, Minicircle Technology, EEV episomal vectors, Cumate-inducible SparQ systems, PhiC31 integrase, and mRNAExpress synthesis), Imaging & Reporter Vectors (pGreenFire signaling reporters, bioluminescent imaging, stem cell reporters), miRNA & lncRNA Research Tools (precursor vectors, miRZIP knockdown, qPCR profiling), and Liquid Biopsy (cfMAX cfDNA isolation). Additionally, SBI provides fee-for-service offerings including Exosome Services, CRISPR/Cas9 Services, Syn2Clone Custom Constructs, Lentivirus Packaging, Stable Cell Lines, Minicircle Services, and RNA Services. The portfolio enables research spanning biomarker discovery, gene therapy development, gene editing validation, stem cell tracking, and T cell immunology studies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Exosome Research Product Suite Complete suite of exosome and extracellular vesicle (EV) products covering isolation, detection, quantitation, labeling, engineering, and biomarker discovery, including ExoQuick UltraPure, SmartSEC kits, ExoELISA-ULTRA, and purified exosome reference materials. Used by academic and industry researchers for biomarker discovery, EV biology, and therapeutic development.
  • CRISPR/Cas9 Systems Complete CRISPR/Cas9 genome editing tools including Cas9 and gRNA delivery vectors, multiplex gRNA cloning, HR targeting vectors, AAVS1 safe harbor targeting, EZ-Genotyping kit, and the CLOuD9 gene expression regulation system. For molecular biology researchers performing gene editing studies.
  • Lentivirus Production Products High-titer lentivirus production products including pPACKH1 HIV-based and pPACKF1 FIV-based packaging kits, pPACK-ID integrase-defective packaging, LentiSuite/LentiStarter kits, virus concentration/titering kits, the 293TN producer cell line, and pre-packaged control viruses for gene delivery research.
  • Gene Expression Systems Viral and non-viral gene expression platforms including lentiviral vectors, AAV vectors, PiggyBac transposon, Minicircle technology, EEV episomal vectors, SparQ cumate-inducible systems, PhiC31 integrase, mRNAExpress synthesis kits, and Cold Fusion cloning. For researchers requiring sustained or inducible gene expression.
  • Imaging and Reporter Vectors Ready-to-use reporter constructs and vectors for bioluminescent imaging (luciferase), fluorescent labeling, signaling pathway analysis (pGreenFire reporters), stem cell monitoring, and Cyto-Tracers for cellular tracking studies.
  • miRNA and lncRNA Research Tools Tools for miRNA and long non-coding RNA research including Lenti-miR precursor vectors, Lenti-miR libraries, miRZIP knockdown vectors, and qPCR profiling arrays for noncoding RNA studies.
  • Liquid Biopsy Research Products

Quantifiable outcome

  • Up to 32-fold gene expression induction with SparQ cumate-inducible systems
  • +3 more outcomes

Companies that use System Biosciences

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles2 records

System Biosciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature11 records

System Biosciences partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Cambridge BiosciencesregionalChannel Partner/ Reseller/ DistributorCambridge Biosciences serves as a regional distributor for SBI products in the UK and Ireland. Academic researchers in these regions can purchase SBI products including minicircle vectors through Cambridge Biosciences.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

System Biosciences competitors and assessment

Company assessment

Direct peers

  • Takara Bio: Takara Bio is a Japan-based molecular biology tools and services company with overlapping lentiviral packaging (Lenti-X), gene expression, CRISPR, and cell engineering offerings. It competes most directly with SBI in lentiviral production kits and custom services for academic and pharma researchers.
  • GenScript: GenScript provides gene synthesis, CRISPR reagents, viral vector services, and protein/peptide tools. Its viral packaging and gene expression offerings overlap heavily with SBI's lentivirus packaging, Syn2Clone, and CRISPR/Cas9 service lines.
  • VectorBuilder: VectorBuilder is a custom vector design and viral packaging service provider (lentivirus, AAV, adenovirus) serving academic and biotech customers. Its custom-cloning and lentivirus-packaging services directly overlap with SBI's Syn2Clone and lentivirus packaging offerings.
  • Mirus Bio: Mirus Bio specializes in transfection reagents (TransIT) and gene delivery tools used in molecular biology and bioprocessing workflows. It is a direct peer in gene delivery reagents, competing with SBI's viral packaging, AAV, and non-viral delivery systems.
  • Cell Biolabs: Cell Biolabs is a San Diego-based life science research tools company offering kits for viral transduction, cell-based assays, exosome research, and gene expression. It is closely comparable to SBI across exosome isolation kits, lentiviral tools, and cell-line reagents.
  • Addgene: Addgene is a nonprofit plasmid repository distributing viral vectors, CRISPR constructs, and recombinant antibodies to academic researchers worldwide. It represents an alternative channel for the same lentiviral and CRISPR plasmids that SBI commercializes, making it a competing route for the same end customer.

Broad incumbents

  • Bio-Techne: Bio-Techne (R&D Systems, Tocris, ProteinSimple) is a large public life-science tools company with broad reagent, antibody, and cell/gene therapy reagent portfolios. It is a broad incumbent competing with SBI across exosome/EV research tools, gene expression reagents, and stem cell research products.
  • Thermo Fisher Scientific: Thermo Fisher is the largest life-science tools and services conglomerate, offering lentiviral packaging, CRISPR reagents, gene expression systems, and custom services through its Life Sciences and Pharma Services segments. It competes with SBI across nearly every product category, although as part of a much wider portfolio.
  • Lonza: Lonza is a leading CDMO with cell and gene therapy manufacturing services including viral vector production. While focused on GMP/clinical-stage manufacturing, Lonza's viral vector services overlap with SBI's custom lentivirus packaging for translational and early-clinical customers.

Emerging players

  • Miltenyi Biotec: Miltenyi Biotec offers cell and gene therapy tools, including lentiviral vectors, exosome/EV isolation reagents, and cell engineering services. It overlaps with SBI in EV research and gene delivery reagents, with growing emphasis on cell therapy workflow tools.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

System Biosciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

System Biosciences leadership team

Management profile

Number of profiles

Profiles5 records

System Biosciences funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

System Biosciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about System Biosciences

What does System Biosciences do?

System Biosciences (SBI) develops, manufactures, and sells molecular and cell biology research tools—including exosome isolation kits, CRISPR/Cas9 gene editing systems, lentiviral packaging kits, gene expression vectors (minicircles, EEV, PiggyBac), imaging/reporters, miRNA/lncRNA tools, and liquid biopsy reagents—through its e-commerce catalog and worldwide distributor network. The company also provides fee-for-service custom research services (lentivirus packaging, stable cell line generation, minicircle production, CRISPR cell engineering, exosome services, RNA services, Syn2Clone constructs) executed at its Palo Alto, California facility.

Is System Biosciences a public or private company?

System Biosciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was System Biosciences founded?

System Biosciences was founded in 2006. It employs 11 to 50 people.

Where is System Biosciences based?

System Biosciences is headquartered in Palo Alto, United States, in the North America region.

How does System Biosciences make money?

Two revenue lines are on record. Research Product Sales are the primary driver. The others are custom Research Services.

Who are System Biosciences's main competitors?

Direct peers on record are Takara Bio, GenScript, VectorBuilder, Mirus Bio, Cell Biolabs and Addgene. Broad incumbents are Bio-Techne, Thermo Fisher Scientific and Lonza. Miltenyi Biotec is listed as an emerging player.

Does System Biosciences have an API?

No public API is recorded for System Biosciences.

What industry is System Biosciences in?

System Biosciences's product category is Life Science Research Reagents. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGANAB, Proteomics & Mass Spectrometry Services. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals